Today in News History

On July 12, several notable moments in the history of News stand out. In 1888, Carl Schmitt, German philosopher and jurist (died 1985) was born. In 1899, E. B. White, American essayist and journalist (died 1985) was born. In 1943, Howard Gardner, American psychologist and academic was born. In 1943, Richard Carleton, Australian journalist (died 2006) was born. In 1943, Peter Jensen, Australian metropolitan was born. In 1953, Ivan Toms, South African physician and activist (died 2008) was born. In 1965, Ernesto Hoost, Dutch kick-boxer and sportscaster was born. In 1968, Michael Geist, Canadian journalist and academic was born. In 2008, Michael E. DeBakey, American surgeon and educator (born 1908) passed away. In 2014, John Seigenthaler, American journalist and academic (born 1927) passed away. Together, these milestones provide historical context for today's news news and ongoing narratives.

Sellas Life Sciences: REGAL Trial's Delayed Events Signal Selection Bias

Seeking Alpha

Seeking Alpha

·

July 9, 2026

·

lean right
Narrative Intelligence Brief

This article was published by Seeking Alpha, a source frequently categorized with a lean right bias based in United States of America. Our narrative intelligence engine continuously monitors coverage from this outlet to track framing, bias, and rhetorical patterns. Our initial algorithmic scan of this specific piece did not flag high-confidence rhetorical techniques, suggesting a generally straightforward reporting style or neutral framing. By understanding the editorial perspective of Seeking Alpha, readers can better contextualize the information presented and compare it across our broader media matrix to find the real narrative.

Analysis Methodology
This narrative analysis was generated using the CoDataLab Global Intelligence Engine. Our proprietary AI scans thousands of cross-border sources to identify sentiment patterns, framing techniques, and potential media bias. While AI provides the data-driven foundation, our objective is to empower readers with additional context beyond the standard headline.The content displayed above is a structured summary designed for rapid information processing. For the full original report, please visit the source outlet.

How other outlets are covering this story

Compare narratives across 6 related reports from 6 sources. Real Narrative News aggregates the coverage spectrum so you can see who emphasises what — bias tags reflect the outlet, not the story.

Coverage bias distribution

6 sources

Left 33%

Center 33%

Right 33%


Seeking Alpha

lean right

· Jun 29, 2026

Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise

Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise

The Motley Fool

lean left

· Jun 29, 2026

Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

NaturalNews.com

right

· Jul 6, 2026

Scoping Review Links Pesticide Exposure to Increased Risks of Childhood Leukemia and Brain Cancer

(NaturalNews) A scoping review published in the International Journal of Cancer on July 1, 2026, examined epidemiologic studies from 1980 to 2022 and found associat...

Dr. Malcolm Kendrick

center

· Mar 21, 2026

Lancet paper critique – Part 3

Finally, you may think, some figures. In this blog I want to look at some of the figures on adverse effects seen in a number of statin trials – such figures as it is possibly to unearth anyway. Unlike the CTT in Oxford I – along with almost every other researcher in the world – []

Medical Daily

center

· Jun 27, 2026

One Sigmoidoscopy Can Protect You from Colon Cancer for Over 20 Years, New Study Finds

A 23-year trial found one sigmoidoscopy reduced colon cancer risk by 28 and death by 37 in men. Here's what this means for people who haven't been screened.

The Next Web

lean left

· Jun 30, 2026

Jon and Mindy Gray bet $55M on AI to catch cancer before it starts

A new institute at Penn’s Basser Center will use artificial intelligence and biomarkers to intercept hereditary cancers at their earliest stages, before they become disease. The idea behind the gift is unusual enough to need its own word. Most cancer philanthropy funds treatment, the long campaign that begins once a tumour has announced itself. Jon [] This story continues at The Next Web

Topics:

Health · 3
Business · 2
Technology · 1

Related coverage for "Sellas Life Sciences: REGAL Trial's Delayed Events Signal Selection Bias": Seeking Alpha — Anavex Life Sciences: Waiting On Validation As Blarcamesine Shows Some Promise. The Motley Fool — Nuvation Bio Stock Is Up 190% Despite Recent Pressure. Should Investors Care About This $753,000 Insider Sale?. NaturalNews.com — Scoping Review Links Pesticide Exposure to Increased Risks of Childhood Leukemia and Brain Cancer. Dr. Malcolm Kendrick — Lancet paper critique – Part 3. Medical Daily — One Sigmoidoscopy Can Protect You from Colon Cancer for Over 20 Years, New Study Finds. The Next Web — Jon and Mindy Gray bet $55M on AI to catch cancer before it starts